Department of Neonatology, Ste Justine Hospital, Cote St Catherine, Montreal, Quebec, Canada.
J Perinatol. 2010 Oct;30(10):677-82. doi: 10.1038/jp.2010.24. Epub 2010 Mar 18.
To describe the various anesthetic techniques used for surgical closure of PDA in premature infants at the Montreal Children's Hospital and assess their impact on postoperative outcome.
The charts of all preterms who underwent PDA ligation during a 21-month period were reviewed for preoperative status, intraoperative anesthetic management and postoperative outcome. We determined the associations between independent variables and two postoperative outcome variables: unstable postoperative respiratory course (UPRC) and hypotension.
The mean weight at surgery of the 33 infants was 1.031±0.29 kg. All infants, but one, received intraoperative opioids. Eight patients presented UPRC. Mean fentanyl doses were 5.3±2.6 mcg kg(-1) for patients with UPRC vs 22.6±16.6 mcg kg(-1) for patients without UPRC (P=0.004). Applying the receiver-operator characteristic curve (ROC), 10.5 mcg kg(-1) of fentanyl was established as the dose that discriminated and identified patients who experienced UPRC. The postnatal and postmenstrual age of the patient, birthweight, current weight, ventilator settings preoperatively, previous courses of indomethacin, sex and preoperative creatinine, were not correlated with the dose of fentanyl equivalent used. Logistic regression did not show a relationship between any of the previously mentioned factors and receiving a fentanyl equivalent of >10.5 mcg kg(-1). The only factor associated with the total fentanyl equivalent dose (as a continuous variable) or receiving <10.5 mcg kg(-1) (as a dichotomous variable) was the identity of the anesthetist involved, P<0.001.
We conclude that the use of at least 10.5 mcg kg(-1) of fentanyl equivalent as a component of the anesthetic regimen for surgical closure of a PDA in premature infants, avoids an unstable postoperative respiratory course.
描述在蒙特利尔儿童医院为早产儿进行动脉导管未闭(PDA)手术缝合时使用的各种麻醉技术,并评估它们对术后结果的影响。
回顾了 21 个月期间所有接受 PDA 结扎术的早产儿的病历,以了解术前情况、术中麻醉管理和术后结果。我们确定了独立变量与两个术后结果变量(不稳定的术后呼吸过程(UPRC)和低血压)之间的关联。
33 名婴儿的手术平均体重为 1.031±0.29kg。所有婴儿均接受了术中阿片类药物治疗,但有 1 例除外。8 例患儿出现 UPRC。接受 UPRC 的患儿芬太尼剂量的平均值为 5.3±2.6mcg kg(-1),而未接受 UPRC 的患儿芬太尼剂量的平均值为 22.6±16.6mcg kg(-1)(P=0.004)。应用接受者操作特征曲线(ROC),10.5mcg kg(-1)的芬太尼被确定为区分和识别经历 UPRC 的患者的剂量。患者的出生后和胎龄、出生体重、当前体重、术前呼吸机设置、先前使用的吲哚美辛疗程、性别和术前肌酐均与使用的芬太尼等效剂量无关。逻辑回归显示,上述任何因素与接受芬太尼等效剂量>10.5mcg kg(-1)之间均无关系。唯一与总芬太尼等效剂量(作为连续变量)或接受<10.5mcg kg(-1)(作为二分类变量)相关的因素是参与麻醉的麻醉师的身份,P<0.001。
我们的结论是,在为早产儿进行 PDA 手术缝合时,将至少 10.5mcg kg(-1)的芬太尼等效物作为麻醉方案的一部分使用,可以避免不稳定的术后呼吸过程。